Nuno Gil

3.6k total citations
19 papers, 140 citations indexed

About

Nuno Gil is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Nuno Gil has authored 19 papers receiving a total of 140 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Nuno Gil's work include Cancer Immunotherapy and Biomarkers (4 papers), Cancer therapeutics and mechanisms (4 papers) and DNA Repair Mechanisms (3 papers). Nuno Gil is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Cancer therapeutics and mechanisms (4 papers) and DNA Repair Mechanisms (3 papers). Nuno Gil collaborates with scholars based in Portugal, Spain and United States. Nuno Gil's co-authors include Rafael Rosell, Mariacarmela Santarpía, N. Oliveira, Joana P. Miranda, Matilde Castro, João G. Costa, Ana S. Fernandes, Nuno Saraiva, S.P. Camões and Unai Cossío and has published in prestigious journals such as International Journal of Molecular Sciences, Biochemical Pharmacology and Journal of Neuroimmunology.

In The Last Decade

Nuno Gil

16 papers receiving 140 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nuno Gil Portugal 8 62 51 49 22 12 19 140
Yei‐San Hsieh Taiwan 6 43 0.7× 79 1.5× 57 1.2× 15 0.7× 9 0.8× 12 147
Anish Kumar Gupta India 5 56 0.9× 66 1.3× 19 0.4× 32 1.5× 6 0.5× 26 189
Imran Rashid Rangraze United Arab Emirates 5 46 0.7× 24 0.5× 38 0.8× 20 0.9× 6 0.5× 41 173
Manuel Ruiz-Echarri Spain 4 52 0.8× 32 0.6× 71 1.4× 8 0.4× 9 0.8× 10 138
Hye-Ryoun Kim South Korea 8 90 1.5× 137 2.7× 103 2.1× 35 1.6× 15 1.3× 13 205
Xiang Fang China 8 54 0.9× 27 0.5× 36 0.7× 21 1.0× 16 1.3× 30 131
Ricardo Simões Brazil 8 29 0.5× 22 0.4× 49 1.0× 18 0.8× 6 0.5× 16 141
Xiaomeng Yin China 7 86 1.4× 64 1.3× 116 2.4× 40 1.8× 9 0.8× 9 235
S. Gadgeel United States 6 48 0.8× 100 2.0× 83 1.7× 22 1.0× 6 0.5× 12 171
Innocent Ogunmwonyi United Kingdom 3 110 1.8× 31 0.6× 69 1.4× 68 3.1× 7 0.6× 5 237

Countries citing papers authored by Nuno Gil

Since Specialization
Citations

This map shows the geographic impact of Nuno Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuno Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuno Gil more than expected).

Fields of papers citing papers by Nuno Gil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuno Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuno Gil. The network helps show where Nuno Gil may publish in the future.

Co-authorship network of co-authors of Nuno Gil

This figure shows the co-authorship network connecting the top 25 collaborators of Nuno Gil. A scholar is included among the top collaborators of Nuno Gil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuno Gil. Nuno Gil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Serra, Patrícia, et al.. (2024). Unveiling Novel ERCC1–XPF Complex Inhibitors: Bridging the Gap from In Silico Exploration to Experimental Design. International Journal of Molecular Sciences. 25(2). 1246–1246. 5 indexed citations
4.
Pinto, Joana, Nuno Gil, Rafael Rosell, et al.. (2024). Impact of the redox-active MnTnHex-2-PyP5+ and cisplatin on the metabolome of non-small cell lung cancer cells. Biochemical Pharmacology. 227. 116424–116424.
5.
Gil, Nuno, et al.. (2024). AI Applied to Volatile Organic Compound (VOC) Profiles from Exhaled Breath Air for Early Detection of Lung Cancer. Cancers. 16(12). 2200–2200. 4 indexed citations
6.
7.
8.
9.
Costa, João G., Nuno Saraiva, Nuno Gil, et al.. (2022). MnTnHex-2-PyP5+ Displays Anticancer Properties and Enhances Cisplatin Effects in Non-Small Cell Lung Cancer Cells. Antioxidants. 11(11). 2198–2198. 10 indexed citations
10.
Costa, João G., Nuno Gil, Jordi Codony‐Servat, et al.. (2021). A narrative review of the migration and invasion features of non-small cell lung cancer cells upon xenobiotic exposure: insights from in vitro studies. Translational Lung Cancer Research. 10(6). 2698–2714. 10 indexed citations
11.
Lemos, Raquel, et al.. (2021). P.0812 Reducing the cognitive burden of prophylactic brain radiotherapy in patients with small cell lung cancer. European Neuropsychopharmacology. 53. S593–S594. 1 indexed citations
12.
Videira, Mafalda, Jordi Llop, Unai Cossío, et al.. (2020). Pulmonary Administration: Strengthening the Value of Therapeutic Proximity. Frontiers in Medicine. 7. 50–50. 14 indexed citations
13.
Ladeira, Filipa, et al.. (2020). Nivolumab-induced seronegative encephalitis. Journal of Neuroimmunology. 347. 577350–577350. 4 indexed citations
14.
Fernandes, Ana S., João G. Costa, Nuno Saraiva, et al.. (2020). Impact of the APE1 Redox Function Inhibitor E3330 in Non-Small Cell Lung Cancer Cells Exposed to Cisplatin: Increased Cytotoxicity and Impairment of Cell Migration and Invasion. Antioxidants. 9(6). 550–550. 30 indexed citations
15.
Gil, Nuno, et al.. (2018). Pulmonary side effects of nivolumab in a patient treated for gynecological malignancy. Radiology Case Reports. 13(3). 542–544. 1 indexed citations
16.
Ito, Masaoki, Carles Codony, Jordi Codony‐Servat, et al.. (2018). 25P A non-pathway-specific approach in EGFR and KRAS mutant or squamous cell histology non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology. 13(4). S13–S14.
17.
Vaz, Sofia C., et al.. (2018). Radiopharmacology and molecular imaging of PD-L1 expression in cancer. Clinical and Translational Imaging. 6(6). 429–439. 7 indexed citations
18.
Santarpía, Mariacarmela, Nuno Gil, & Rafael Rosell. (2015). Strategies to overcome resistance to tyrosine kinase inhibitors in non-small-cell lung cancer. Expert Review of Clinical Pharmacology. 8(4). 461–477. 28 indexed citations
19.
Lavrador, José Pedro, et al.. (2014). C1–C2 pigmented villonodular synovitis and clear cell carcinoma: unexpected presentation of a rare disease and a review of the literature. European Spine Journal. 24(S4). 465–471. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yei‐San Hsieh Breakdown of academic impact, for papers by Anish Kumar Gupta Breakdown of academic impact, for papers by Imran Rashid Rangraze Breakdown of academic impact, for papers by Manuel Ruiz-Echarri Breakdown of academic impact, for papers by Hye-Ryoun Kim Breakdown of academic impact, for papers by Xiang Fang Breakdown of academic impact, for papers by Ricardo Simões Breakdown of academic impact, for papers by Xiaomeng Yin Breakdown of academic impact, for papers by S. Gadgeel Breakdown of academic impact, for papers by Innocent Ogunmwonyi
Rankless by CCL
2026